Guggenheim Capital LLC Lantheus Holdings, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 24,132 shares of LNTH stock, worth $2.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,132

Previous 24,388 1.05%

Holding current value

$2.2 Million

Previous $1.96 Million 35.24%

% of portfolio

0.02%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$77.7 - $123.62 $19,891 - $31,646	-256 Reduced 1.05%	24,132 $2.65 Million
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $2.53 Million - $3.57 Million	-42,979 Reduced 63.8%	24,388 $1.96 Million
Q1 2024 May 14, 2024	BUY	$51.07 - $68.26 $2.04 Million - $2.73 Million	40,041 Added 146.53%	67,367 $4.19 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $11,231 - $15,733	-202 Reduced 0.73%	27,326 $1.69 Million
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $160,679 - $241,939	2,666 Added 10.72%	27,528 $1.91 Million
Q2 2023 Aug 11, 2023	BUY	$82.41 - $99.65 $169,022 - $204,382	2,051 Added 8.99%	24,862 $2.09 Million
Q1 2023 May 10, 2023	BUY	$47.76 - $82.86 $284,745 - $494,011	5,962 Added 35.38%	22,811 $1.88 Million
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $821,557 - $1.31 Million	16,849 New	16,849 $858,000
Q2 2018 Aug 14, 2018	SELL	$13.65 - $18.7 $474,078 - $649,469	-34,731 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$14.85 - $24.3 $155,316 - $254,153	-10,459 Reduced 23.14%	34,731 $552,000
Q4 2017 Feb 14, 2018	SELL	$17.4 - $23.4 $1.41 Million - $1.89 Million	-80,903 Reduced 64.16%	45,190 $926,000
Q3 2017 Nov 14, 2017	BUY	$15.5 - $19.15 $1.95 Million - $2.41 Million	126,093	126,093 $2.24 Million

Others Institutions Holding LNTH

# of Institutions

540

Shares Held

68M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Lantheus Holdings, Inc. Transaction History